Prevalence (%) (95% CI) | |||||
---|---|---|---|---|---|
Characteristic | Anti-HCV | Anti-HBV | Anti-HAV | Anti-HIV | Anti-HSV-2 |
Antibody to HCV | |||||
Positive | -- | 27.1 (13.9 - 46.0)a | 61.2 (34.5 - 82.5) | 2.2 (0.5 - 8.6) | 55.4 (30.9 - 77.6)b |
Negative | -- | 2.7 (2.0 - 3.8) | 40.9 (37.8 - 44.1) | 0.8 (0.4 - 1.6) | 21.7 (18.5 - 25.3) |
Antibody to HBV | |||||
Positive | 17.4 (8.5 - 32.3)a | -- | 71.5 (56.7 - 82.7)a | -- | 39.9 (27.5 - 53.7)b |
Negative | 1.7 (1.0 - 2.8) | -- | 40.3 (37.1 - 43.6) | -- | 21.7 (18.6 - 25.3) |
Antibody to HAV | |||||
Positive | 3.3 (1.8 - 6.1) | 5.7 (3.9 - 8.3)a | -- | 1.4 (0.6 - 3.0) | 29.4 (24.8 - 34.5)a |
Negative | 1.4 (0.6 - 3.2) | 1.6 (1.0 - 2.7) | -- | 0.5 (0.1 - 1.7) | 17.6 (14.2 - 21.5) |
Antibody to HIV | |||||
Positive | 5.2 (1.0 - 23.0) | -- | 66.2 (29.5 - 90.1) | -- | 89.3 (57.0 - 98.1)a |
Negative | 2.2 (1.3 - 3.5) | -- | 41.1 (37.9 - 44.4) | -- | 21.9 (18.7 - 25.4) |
Antibody to HSV-2 | |||||
Positive | 5.1 (2.5 - 10.1)b | 6.2 (3.9 - 9.8)b | 53.7 (46.5 - 60.8)a | 3.0 (1.2 - 6.9)a | -- |
Negative | 1.2 (0.6 - 2.3) | 2.7 (1.8 - 3.9) | 36.9 (33.9 - 40.0) | 0.1 (0.02 - 0.4) | -- |